Report PDF 1

Mrs. SHEELA M RAHATWAL Reference: DR.
BHARATKUMAR VID: 240140102223858

MIRA ROAD Thane.. CHAUDHARY Registered On:
Tel No : 9769351716 Sample Collected At:
08/06/2024 08:53 AM
Tarunaben Kantilal Mehta
PIN No: 401107 Holy Complex Shop No 10 D E Wing Collected On:
PID NO: P42724525284086 Near Thunga Hospital Thane 401107. 08/06/2024 8:40AM
Age: 66 Year(s) Sex: Female Zone: C-19c(50) Reported On:
Processing Location:- Metropolis
Healthcare Ltd. Ganjawala Lane, Borivali 08/06/2024 09:23 PM
(W).
Investigation Observed Value Unit Biological Reference Interval

Glucose fasting 127.7 mg/dL Normal: 70-99
(Plasma-F,Hexokinase) Impaired Fasting Glucose(IFG):
100-125
Diabetes mellitus: >= 126
(on more than one occassion)
(American diabetes association
guidelines 2022)
Note: An individual may show higher fasting glucose level in comparison to post prandial glucose level due to following reasons :
The glycaemic index and response to food consumed, Changes in body composition, Increased insulin response and sensitivity,
Alimentary hypoglycemia, Renal glycosuria, Effect of oral hypoglycaemics & Insulin treatment.
Associated Tests: HbA1c (H0018), Diabetes Profile – Maxi (D0021),HOMA Index (H0275), Insulin (I0275).
Creatinine 0.82 mg/dL 0.60-1.10

(Serum,Jaffe) Note : Change in Reference
range
CRP - C Reactive Protein 1.14 mg/L < 5.0
(Serum,Particle enhanced immunoturbidimetric
assay)
Interpretation :
• Measurement of CRP is useful for the detection and evaluation of infection, tissue injury, inflammatory disorders and
associated diseases .
• High sensitivity CRP (hsCRP) measurements may be used as an independent risk marker for the identification of individual
at risk for future cardiovascular disease.
• Increase in CRP values are non-Specific and should not be interpreted without a complete history.
Note :
If the test has been ordered for COVID-19 purpose, you may take one of the following profiles for further investigation under your
clinician’s advice.
• Covid Monitor Initial profile (C0374) from Day 1 to Day 5
• Covid Monitor maintenance profile (C0375) from Day 5 to Day 10
• Covid Monitor Recovery profile (C0376) after discharge.
Dr. Bhavna Vora

Page 1 of 5 MD Pathology
Mrs. SHEELA M RAHATWAL Reference: DR.BHARATKUMAR VID: 240140102223858
08/06/2024 08:53 AM
(W).

TSH(Ultrasensitive) 2.28 µIU/mL 0.54-5.3
(Serum,ECLIA) First Trimester : 0.33-4.59
Second Trimester : 0.35-4.10
Third trimester : 0.21-3.15
Interpretation :
• Increased TSH is seen with intake of Iodine, Lithium, Amiodarone drugs and also indicates considerable physiologic &
seasonal variation.
• Decreased TSH values require correlation with patient age & clinical symptoms and seen with intake of few drugs e.g. L-
dopa, glucocorticoids.
• Transient alteration in TSH is seen in non-thyroidal illness like severe infections, liver disease, renal and heart failure, severe
burns, trauma and surgery etc.
Clinical Utility: Levels of TSH are used for monitoring of thyroid related disorders.
Caution: Patients on Biotin supplement may have interference in some immunoassays. For sample collection, at least 8-hours wait
time is recommended for individuals taking high dose of Biotin (more than 5 mg per day) supplements.
Note: TSH levels may fluctuate based on few factors such as pregnancy, illness and age. Also, time of sample collection,
technologies used to analyze the test, usage of certain drugs, diet may have impact on TSH levels. TSH may show around 50%
variation even when done at different times of day due to its association with circadian rhythm.
Associated Tests: T3 (T0029), T4 (T0031) free T3 (T0028), free T4 (T0030), reverse T3 (R1004), Thyroid Antibodies (T0061),
Thyroid Comprehensive Profile-1 (T0062)
Reference:
• Clinical Chemistry 50:12, 2338-2344 (2004) and Ind J Clin Biochem (Apr-June 2014) 29(2):189–195.
• Ref: Arch Pathol Lab Med—Vol 141, November 2017.
• Fisher DA. Physiological variations in thyroid hormones: physiological and pathophysiological considerations. Clin Chem.
1996 Jan;42(1):135-9. PMID: 8565215
Dr. Bhavna Vora

08/06/2024 08:53 AM
(W).
CBC+MP
CBC Haemogram
Erythrocytes
Haemoglobin (Hb) 15.4 gm/dL 12.0-16
Erythrocyte (RBC) Count 4.97 mill/cu.mm 4.2-5.4
PCV (Packed Cell Volume) 45.9 % 37-47
MCV (Mean Corpuscular Volume) 92.4 fL 82-101
MCH (Mean Corpuscular Hb) 30.9 pg 27-34
MCHC (Mean Corpuscular Hb Concn.) 33.5 g/dL 31.5-36
RDW (Red Cell Distribution Width) 11.5 % 11.5-14.0
RBC Morphology
Remark Normocytic Normochromic
Leucocytes
Total Leucocytes (WBC) count 8,290 cells/cu.mm 4300-10300
Absolute Neutrophils Count 2868 /c.mm 2000-7000
Absolute Lymphocyte Count 4717 /c.mm 1000-3000
Absolute Monocyte Count 464 /c.mm 200-1000
Absolute Eosinophil Count 174 /c.mm 20-500
Absolute Basophil Count 66 /c.mm 20-100
Neutrophils 34.6 % 40-80
Lymphocytes 56.9 % 20-40
Monocytes 5.6 % 2.0-10
Eosinophils 2.1 % 1-6
Basophils 0.8 % 0-2
Platelets
Platelet count 364 10^3 / µl 140-440
MPV (Mean Platelet Volume) 10.1 fL 7.8-11
PCT ( Platelet Haematocrit) 0.370 % 0.2-0.5
PDW (Platelet Distribution Width) 14.8 % 9-17
EDTA Whole Blood - Tests done on Automated Five Part Cell Counter. (WBC, RBC Platelet count by impedance method, WBC
differential by VCS technology other parameters calculated) All Abnormal Haemograms are reviewed confirmed microscopically.
Differential count is based on approximately 10,000 cells.
Dr. Bhavna Vora

08/06/2024 08:53 AM
(W).
Investigation Observed Value Biological Reference Interval

Malaria Parasite Detection by Smear examination
(EDTA Whole Blood)
Malaria Parasite examination on thick Absent Absent
Smear
Malaria Parasite examination on thin Absent Absent
Smear
Method : Microscopy .
Interpretation:
1. Parasites are usually seen during febrile episode.

2. Peripheral smear has sensitivity of 86.79% and hence repeated smear examination can be required to rule out false
negativity.
3. Peripheral smear examination is a screening test and other methods like QBC (quantitative buffy coat), malaria antigen test
and PCR should be used for confirmation especially in low parasitic index.
4. Parasitic index reflects severity of infestation (parasites per 100 RBC).
5. Parasitemia after adequate therapy is indicative of resistant strains.
Associated Test:
• “Fever Panel by Multiplex PCR” for early diagnosis of Dengue virus, Chikungunya virus, Salmonella spp., West Nile virus,
Plasmodium spp., Rickettsia spp. and Leptospira spp.
Dr. Bhavna Vora

08/06/2024 08:53 AM
PIN No: 401107 Holy Complex Shop No 10 D E Wing Near Collected On:
PID NO: P42724525284086 Thunga Hospital Thane 401107.Zone: C- 08/06/2024 8:40AM
Age: 66 Year(s) Sex: Female 19c(50) Reported On:
Healthcare Ltd,Unit No409-416,4th 08/06/2024 09:23 PM
Floor,Commercial Building-1,Kohinoor
Mall,Mumbai-70

Dengue (NS1) antigen Negative,0.016 Ratio Negative: < 1
(Serum,CLIA) Positive: > 1
Please Note change in
Reference range method and
unit.
Interpretation:
Dengue NS1 Dengue IgM Dengue IgG Suspected of
+ - - Active Dengue Early infection
+ + - Primary Dengue infection-
+ - + Primary initial stage infection/
cross reactivity
- + + Concurrent/ Recurrent
Infection
- - + Past Infection
+ -/+ - Secondary infection
- - - Not Dengue, other
investigations needed.
•If Dengue NS1 is detected positive, concurrent testing with Dengue IgM is advised to know the type of infection-Primary
orSecondary.
• Negative NS1 antigen results may occur if the specimen was collected greater than 7 days following symptom onset.
Caution
• A negative Dengue NS1 antigen does not rule out possibility of exposure to or infection with dengue virus.
• False positive Dengue NS1 antigen results may be seen in individuals with other flaviviruses west nile virus as well as Yellow
fever.
• High titre of heterophile antibodies or rheumatoid factor may interfere with the results.
Note: As per regulation, specimen collecting Laboratory is responsible for reporting positive Dengue & Leptospira cases to
Municipal corporation.
Associated test: Dengue IgM Test code (D0004) & Dengue IgG Test code( D0003). Dengue Virus PCR Test code (D0008).
References:
• CDC: Dengue. Accessed 13/09/2019. Available at: www.cdc.gov/Dengue/
• World Health Organization. Dengue: guidance for diagnosis, surveillance and control WHO, Geneva (2009) Available at:
http://www.who.int/zoonoses/resources/denguecontrol/en/
-- End of Report --
Tests marked with NABL symbol are accredited by NABL vide Certificate no MC-2139; Validity till 01-06-2024
Page 5 of 5
Dr. ALAP CHRISTY
MBBS, MD, PGDM-HC Head -
Clinical Chemistry
Reg No.2020/12/6991

Report PDF 1

Uploaded by

Copyright:

Available Formats

Report PDF 1

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Report PDF 1

Uploaded by

Copyright:

Available Formats

Mrs. SHEELA M RAHATWAL Reference: DR.

BHARATKUMAR VID: 240140102223858

Investigation Observed Value Unit Biological Reference Interval

Creatinine 0.82 mg/dL 0.60-1.10

Dr. Bhavna Vora

Investigation Observed Value Unit Biological Reference Interval

Dr. Bhavna Vora

Dr. Bhavna Vora

Investigation Observed Value Biological Reference Interval

1. Parasites are usually seen during febrile episode.

Dr. Bhavna Vora

Investigation Observed Value Unit Biological Reference Interval

You might also like

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.